Market Research Logo

Tanzania Pharmaceuticals and Healthcare Report Q2 2016

Tanzania Pharmaceuticals and Healthcare Report Q2 2016

BMI View: Tanzania continues to suffer from pharmaceutical supply chain weaknesses that weaken the market's attractiveness to multinational pharmaceutical companies. While the government has recognised the need to improve the situation and is implementing certain strategies to this end, the large funding gap and pre-existing structural issues will continue to hinder patients' access to essential medicines. We highlight, however, that access to healthcare services will improve as the country's National Health Insurance Scheme gains traction. Headline Expenditure Projections Pharmaceuticals: TZS899bn (USD441mn) in 2015 to an expected TZS1.02trn (USD468mn) in 2016; +13.6% growth in local currency terms and +6.0% in US dollar terms. Forecast maintained from Q116. Healthcare: TZS4.62trn (USD2.27bn) in 2015 to TZ5.08trn (USD2.32bn) in 2016; +9.9% growth in local currency terms, and +2.5% in US dollar terms. Forecast maintained from Q116.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Tanzania 2014-2020)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Tanzania 2012-2020)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Tanzania 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Tanzania 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Tanzania 2012-2020)
Pharmaceutical Trade Forecast
Table: PHARMACEUTICAL TRADE DATA AND FORECASTS (TANZANIA 2014-2020)
Table: PHARMACEUTICAL TRADE DATA AND FORECASTS LOCAL CURRENCY (TANZANIA 2014-2020)
Industry Risk/Reward Index
Middle East and Africa Risk/Reward Index - Q2 2016
Tanzania Risk/Reward Index
Rewards
Risks
Regulatory Review
Intellectual Property Issues
Pricing Regime
Market Overview
Healthcare Sector
Research & Development
Clinical Trials
Epidemiology
Competitive Landscape
Research-Based Industry
Table: Multinational Market Activity
Generic Drugmakers
Pharmaceutical Retail Sector
Demographic Forecast
Table: Population Headline Indicators (Tanzania 1990-2025)
Table: Key Population Ratios (Tanzania 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Tanzania 1990-2025)
Table: Population By Age Group (Tanzania 1990-2025)
Table: Population By Age Group % (Tanzania 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report